University of Pennsylvania; Abramson Cancer Center; Lymphoma Program is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
University of Pennsylvania; Abramson Cancer Center; Lymphoma Program has participated in 1 clinical trials.
Therapeutic areas: Follicular Lymphoma, Marginal Zone B-Cell Lymphoma, MALT Lymphoma.
Sponsors: Abramson Cancer Center at Penn Medicine.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pennsylvania; Abramson Cancer Center; Lymphoma Program has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pennsylvania; Abramson Cancer Center; Lymphoma Program has 1 clinical trials on record. Their work covers Follicular Lymphoma, Marginal Zone B-Cell Lymphoma, MALT Lymphoma.
University of Pennsylvania; Abramson Cancer Center; Lymphoma Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.